simvastatin has been researched along with sphingosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia, JG; Jacobson, JR | 1 |
| Badimon, L; González-Díez, M; Martínez-González, J; Rodríguez, C | 1 |
| Im, DS; Kimura, T; Kurose, H; Kuwabara, A; Mogi, C; Murakami, M; Okajima, F; Sato, K; Tomura, H | 1 |
| Kim, JH; Kim, KH; Kim, MB; Kim, YM; Ko, HC; Lee, MJ | 1 |
| Fu, P; Harijith, A; Jacobson, JR; Karginov, A; Natarajan, V; Shaaya, M | 1 |
1 review(s) available for simvastatin and sphingosine
| Article | Year |
|---|---|
Novel therapies for microvascular permeability in sepsis.
Topics: Adenosine Triphosphate; Animals; Capillaries; Capillary Permeability; Dogs; Humans; Lysophospholipids; Protein C; Sepsis; Simvastatin; Sphingosine; Venules | 2007 |
4 other study(ies) available for simvastatin and sphingosine
| Article | Year |
|---|---|
Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
Topics: Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Induction; Epoprostenol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Receptors, Lysosphingolipid; RNA Interference; RNA, Messenger; RNA, Small Interfering; Simvastatin; Sphingosine; Sphingosine-1-Phosphate Receptors; Suramin; Time Factors; Up-Regulation | 2008 |
Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells.
Topics: Animals; Blotting, Western; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Endothelial Cells; Enzyme Activation; Humans; Hypolipidemic Agents; Immunoenzyme Techniques; Inflammation; Lipoproteins, HDL; Lysophospholipids; Mice; Monocytes; Nitric Oxide Synthase; PPAR alpha; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; Scavenger Receptors, Class B; Simvastatin; Sphingosine; Transfection; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2008 |
Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells.
Topics: Amides; Blotting, Western; Cell Differentiation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Mesenchymal Stem Cells; Myocytes, Smooth Muscle; Phosphorylcholine; Pyridines; rhoA GTP-Binding Protein; Simvastatin; Sphingosine | 2012 |
Sphingolipids Signaling in Lamellipodia Formation and Enhancement of Endothelial Barrier Function.
Topics: Acute Lung Injury; Endothelium, Vascular; Humans; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); Pseudopodia; Reactive Oxygen Species; Signal Transduction; Simvastatin; Sphingolipids; Sphingosine | 2018 |